Pathologic anatomy of early-stage breast cancer and its relevance to APBI: Defining the target

Accelerated Partial Breast Irradiation (Second Edition)

Volumn , Issue , 2009, Pages 35-45

  Jolly, Shruti ^a   Kestin, Larry L ^b   Goldstein, Neal S ^b   Vicini, Frank A ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892326479     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-88006-6_3     Document Type: Chapter

References (36)

1. Arthur DW, Winter K, Kuske RR, et al. (2008) A phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17. Int J Radiat Oncol Biol Phys 72(2):467-473
2. Clark RM, McCulloch PB, Levine MN, et al. (1992) Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84:683-689
3. Clark RM, Whelan T, Levine M, et al. (1996) Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88:1659-1664
4. Faverly D, Holland R, Burgers L (1992) An original stereomicroscopic analysis of the mammary glandular tree. Virchows Arch A Pathol Anat Histopathol 421:115-119
5. Fisher B, Anderson S, Bryant J, et al. (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241
6. Forrest AP, Stewart HJ, Everington D, et al. (1996) Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 348:708-713
7. Goldstein NS, Kestin L, Vicini F (2003) Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy. A clinicopathologic study of 607 neoplasms from 583 patients. Am J Clin Pathol 120:500-527
8. Holland R, Veling SH, Mravunac M, et al. (1985) Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56:979-990
9. Imamura H, Haga S, Shimizu T, et al. (2000) Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age. Breast Cancer Res Treat 62:177-184
10. Keisch M, Vicini FA, Kuske RR, Hebert M, White J, Quiet C, Arthur D, Scroggins T, Streeter O (2003) Initial clinical experience with MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 55:289-293
11. Kestin LL, Jaffray DA, Edmundson GK, et al. (2000) Improving the dosimetric coverage of interstitial high-dose-rate breast implants. Int J Radiat Oncol Biol Phys 46:35-43
12. King TA, Bolton JS, Kuske RR, et al. (2000) Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T (is, 1, 2) breast cancer. Am J Surg 180:299-304
13. Kollias J, Man S, Marafie M, et al. (2000) Loss of heterozygosity in bilateral breast cancer. Breast Cancer Res Treat 64:241-251.
14. Krauss DJ, Kestin LL, Mitchell C, et al. (2004) Changes in temporal patterns of local failure after breastconserving therapy and their prognostic implications. Int J Radiat Oncol Biol Phys 60:731-740
15. Kung FY, Tse GM, Lo KW, et al. (2002) Metachronous bilateral mammary metaplastic and infiltrating duct carcinomas: a molecular study for clonality. Hum Pathol 33:677-679
16. Kuske RR, Winter K, Arthur DW, et al. (2006) Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17. Int J Radiat Oncol Biol Phys 65:45-51
17. Leong PP, Rezai B, Koch WM, et al. (1998) Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst 90:972-977
18. Liljegren G, Holmberg L, Adami HO, et al. (1994) Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst 86:717-722
19. Lininger RA, Fujii H, Man YG, et al. (1998) Comparison of loss heterozygosity in primary and recurrent ductal carcinoma in situ of the breast. Mod Pathol 11:1151-1159
20. McGrath SD, Vicini FA, Antonucci J, Wallace M, Lestin LL, Schell S (2007) Long-term patterns of in-breast failure in patients with early stage breast cancer treated with breast conserving therapy: a molecular based clonality evaluation. In: 49th Annual Meeting of American Society for Therapeutic Radiology and Oncology, Los Angeles, CA, 28 Oct-1 Nov. 2007
21. Mead LJ, Gillespie MT, Hung JY, et al. (1997) Frequent loss of heterozygosity in early non-small cell lung cancers at chromosome 9p21 proximal to the CDKN2a gene. Int J Cancer 71:213-217
22. Ohtake T, Abe R, Kimijima I, et al. (1995) Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer 76:32-45
23. Regitnig P, Moser R, Thalhammer M, et al. (2002) Microsatellite analysis of breast carcinoma and corresponding local recurrences. J Pathol 198:190-197
24. Regitnig P, Ploner F, Maderbacher M, et al. (2004) Bilateral carcinomas of the breast with local recurrence: analysis of genetic relationship of the tumors. Mod Pathol 17:597-602
25. Renton SC, Gazet JC, Ford HT, et al. (1996) The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol 22:17-22
26. Smith TE, Lee D, Turner BC, et al. (2000) True recurrence vs. New primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 48:: 1281-1289
27. Tse GM, Kung FY, Chan AB, et al. (2003) Clonal analysis of bilateral mammary carcinomas by clinical evaluation and partial allelotyping. Am J Clin Pathol 120:168-174
28. Veronesi U, Luini A, Del Vecchio M, et al. (1993) Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 328:1587-1591
29. Veronesi U, Cascinelli N, Mariani L, et al. (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232
30. Vicini FA, Kestin LL, Edmundson GK, et al. (1999) Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys 45:803-810
31. Vicini FA, Kestin L, Chen P, et al. (2003) Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 95:1205-1210
32. Vicini FA, Kestin LL, Goldstein NS (2004) Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int J Radiat Oncol Biol Phys 60:722-730
33. Vicini FA, Winter K, Straube W, Wong J, Pass H, Rabinovitch R, Chafe S, Arthur D, Petersen I, McCormick B (2005) A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Int J Radiat Oncol Biol Phys 63:1531-1537
34. Vicini FA, Beitsch PD, Quiet CA, Keleher AJ, Garcia D, Snider HC, Gittleman MA, Zannis VJ, Kuerer HM, Lyden M (2008a) Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 112:758-766
35. Vicini FA, Goldstein NS, Wallace M, et al. (2008b) Molecular evidence demonstrating local treatment failure is the source of distant metastases in some patients treated for breast cancer. Int J Radiat Oncol Biol Phys 71:689-694
36. Wallner P, Arthur D, Bartelink H, et al. (2004) Workshop on Partial Breast Irradiation: State of the Art and the Science, Bethesda, MD, December 8-10, 2002. J Natl Cancer Inst 96:175-184